Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Biota Pharmaceuticals Inc    NABI

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Operates as an anti-infective drug development company

Aviragen Therapeutics, Inc. engages in the discovery and development of direct-acting antivirals to treat infections.

Its product candidates include vapendavir, an oral treatment for human rhinovirus infections in moderate-to-severe asthmatics, currently being evaluated in ongoing Phase 2b SPIRITUS trial; BTA074, a Phase 2 topical antiviral treatment for genital warts caused by human papillomavirus types 6 & 11; BTA585, an oral fusion protein inhibitor in Phase 1 development for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a one-time, inhaled treatment in Phase 2 development for influenza A and B infections.

The company was founded on November 8, 2012 and is headquartered in Alpharetta, GA.
Managers
NameAgeSinceTitle
Joseph M. Patti, PhD532012President, CEO & Executive Director
Russell H. Plumb MBA, CPA582012Executive Chairman
Mark P. Colonnese MBA, CPA612015Chief Financial Officer & Executive Vice President
John H. Vernachio, PhD-2014Vice President-Preclinical Development
Geoffrey F. Cox, PhD732012Independent Non-Executive Director
Anne M. VanLent692013Lead Independent Non-Executive Director
Michael R. Dougherty592013Independent Non-Executive Director
John P. Richard, MBA592013Independent Non-Executive Director
Armando Anido, MBA592015Independent Non-Executive Director
Michael W. Dunne, MD572015Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 38,649,237 34,881,866 90.3% 0 0.0% 90.3%
Shareholders
NameEquities%
Broadfin Capital LLC 3,486,711 9.02%
East Hill Management Co. LLC 3,456,520 8.94%
Krensavage Asset Management LLC 2,737,602 7.08%
Senzar Asset Management LLC 1,774,876 4.59%
The Vanguard Group, Inc. 1,051,643 2.72%
Renaissance Technologies LLC 759,005 1.96%
BlackRock Fund Advisors 571,912 1.48%
Fidelity Management & Research Co. 465,701 1.20%
Landon Thomas Clay 327,672 0.85%
Stonepine Capital Management LLC 309,278 0.80%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Sector Bio Therapeutic Drugs
1st jan.Capitalization (M$)
BIOTA PHARMACEUTICALS ..23
AMGEN, INC.14.53%123 319
CELGENE CORPORATION6.58%95 978
GILEAD SCIENCES, INC.-5.28%88 658
REGENERON PHARMACEUTIC..0.56%39 159
ACTELION LTD24.49%29 874
VERTEX PHARMACEUTICALS..22.22%22 369
GENMAB A/S20.63%12 303
TESARO INC15.84%8 354
EXELIXIS, INC.37.36%5 957
HUALAN BIOLOGICAL ENGI..--.--%4 980
TONGHUA DONGBAO PHARMA..-2.46%4 416
KITE PHARMA INC70.34%4 188
NEUROCRINE BIOSCIENCES..7.80%3 634
BLUEBIRD BIO INC39.87%3 525
BIOCON LTD21.29%3 470
ULTRAGENYX PHARMACEUTI..11.45%3 270
CLOVIS ONCOLOGY INC51.24%2 998
INTERCEPT PHARMACEUTIC..6.99%2 887
PEPTIDREAM INC-12.66%2 734
CHINA BIOLOGIC PRODUCT..-7.16%2 714
Sector Bio Therapeutic Drugs
Biota Pharmaceuticals Inc : Connections
Massachusetts Biotechnology Council
Lakewood-Amedex, Inc.
Beacon Street Advisors LLC
Zygogen LLC
Altherx, Inc.
SciStem Therapeutics, Inc.
Shire ViroPharma, Inc.
Phase4 Partners Ltd.
Cempra Pharmaceuticals, Inc.
Altiris Therapeutics, Inc.
Pennsylvania Biotechnology Association
Georgia Venture Partners LLC
International AIDS Vaccine Initiative, Inc.
AMV Advisors
QUE Oncology, Inc.
Iterum Pharmaceuticals LLC
Company contact information
Aviragen Therapeutics, Inc.
2500 Northwinds Parkway
Suite 100
Alpharetta, GA 30009

Phone : +1.678.221.3343
Web : www.aviragen.com
© 2017 People , Fundamentals and Ownership